Cargando…
Predictors of Recurrent Ductal Carcinoma In Situ after Breast-Conserving Surgery
PURPOSE: Local recurrence is a major concern in patients who have undergone surgery for ductal carcinoma in situ (DCIS). The present study assessed whether the expression levels of hormone receptors, human epidermal growth factor receptor 2 (HER2), and Ki-67, as well as resection margin status, tumo...
Autores principales: | Kim, Jung Yeon, Park, Kyeongmee, Kang, Guhyun, Kim, Hyun-Jung, Gwak, Geumhee, Shin, Young-Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929260/ https://www.ncbi.nlm.nih.gov/pubmed/27382395 http://dx.doi.org/10.4048/jbc.2016.19.2.185 |
Ejemplares similares
-
Prognostic Significance of a Micropapillary Pattern in Pure Mucinous Carcinoma of the Breast: Comparative Analysis with Micropapillary Carcinoma
por: Kim, Hyun-Jung, et al.
Publicado: (2017) -
Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer
por: Park, Kyeongmee, et al.
Publicado: (2011) -
Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer
por: Choi, Young Jin, et al.
Publicado: (2016) -
Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting
por: Habel, Laurel A, et al.
Publicado: (2009) -
Is radiotherapy necessary for intermediate risk ductal carcinoma in situ after breast conserving surgery?
por: Kim, Taeryung, et al.
Publicado: (2014)